Thomas Flaten

Q: What is Thomas Flaten's success rate?

Thomas Flaten currently has a success rate of 66.06151454277651.

Q: What is the average return of Thomas Flaten's calls?

Their stock ratings have generated an average return of 20.4495685067422.

Lake Street | Healthcare

Thomas Flaten is an analyst from Lake Street specializing in the Healthcare sector. Ranked #2312 out of 4738 analysts, they have issued 16 stock ratings with a success rate of 66.06% and an average return of 20.45%.

With 16 ratings to date, Thomas Flaten is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 66.06% and an average return of 20.45%, highlighting promising potential as their track record develops further.

#2312

Out of 4738

Total Ratings

+66.06%

Success Rate

+20.45%

Average Return

Recent Ratings Analysis

PSNL

Hold

Jul 20, 2026

Target

$16.25

Current

$13.44

Performance

0.75%

Thomas Flaten rated PSNL as Hold on Jul 20, 2026, setting a price target of 16.25. The Hold stance appears justified, as shares hovered around 13.44 with a 0.75% move.

VANI

Buy

Jun 23, 2026

Target

$4.00

Current

$1.43

Performance

20.17%

On Jun 23, 2026, VANI was given a Buy rating by Thomas Flaten, with a target price of 4. The stock rallied 20.17% after the rating, narrowing the gap to the target of 4 and validating the bullish stance.

RPID

Buy

May 22, 2026

Target

$7.00

Current

$2.10

Performance

2.44%

RPID received a Buy rating from Thomas Flaten on May 22, 2026, aiming for 7. Price action was muted, as shares hovered around 2.1 despite the bullish outlook.

MDXH

Buy

May 14, 2026

Target

$5.00

Current

$0.42

Performance

-57.04%

On May 14, 2026, Thomas Flaten published a Buy outlook on MDXH, with a target of 5. Market action contradicted the Buy thesis, as shares slipped to 0.423.

ASRT

Hold

May 13, 2026

Target

$23.50

Current

$23.50

Performance

0.77%

Thomas Flaten on May 13, 2026 assigned ASRT a Hold rating, with a price target of 23.5. The Hold stance reflected consolidation, as shares held near 23.5.

EVAX

Buy

Mar 09, 2026

Target

$11.00

Current

$3.02

Performance

-1.95%

On Mar 09, 2026, Thomas Flaten reaffirmed EVAX with a Buy rating, targeting 11. Market indecision has kept the 11 target in a holding pattern.

IMDX

Buy

Feb 17, 2026

Target

$12.00

Current

$5.00

Performance

-7.24%

IMDX was rated Buy by Thomas Flaten on Feb 17, 2026, with a price objective of 12. This case shows how bullish projections can fail, with the stock now below 5.

CSTL

Buy

Jan 12, 2026

Target

$52.00

Current

$24.51

Performance

-38.20%

On Jan 12, 2026, Thomas Flaten initiated coverage on CSTL with a Buy rating and target of 52. The Buy call has yet to be validated as shares remain 27.49 away from the target.

PTHS

Buy

Dec 03, 2025

Target

$50.00

Current

$26.86

Performance

2.52%

Thomas Flaten issued a Buy recommendation for PTHS on Dec 03, 2025, price target set at 50. The target of 50 remains in play, though confirmation will depend on future moves.

CNTB

Buy

Dec 01, 2025

Target

$9.00

Current

$2.21

Performance

-20.22%

On Dec 01, 2025, CNTB was evaluated by Thomas Flaten, who gave a Buy rating and target of 9. Investors saw limited payoff as shares fell short of the 9 target.

HROW

Buy

Sep 29, 2025

Target

$70.00

Current

$43.71

Performance

-9.69%

Thomas Flaten rated HROW as Buy on Sep 29, 2025, setting a price target of 70. The stock has underperformed, dropping 9.69% despite the bullish target of 70.

DERM

Buy

Aug 13, 2025

Target

$13.00

Current

$7.31

Performance

0.83%

On Aug 13, 2025, DERM was given a Buy rating by Thomas Flaten, with a target price of 13. The stock traded sideways with a 0.83% move, keeping the bullish thesis unresolved.

DMAC

Buy

Jul 18, 2025

Target

$14.00

Current

$7.08

Performance

69.38%

DMAC received a Buy rating from Thomas Flaten on Jul 18, 2025, aiming for 14. Momentum has favored the Buy call, with shares climbing from 7.08 to 7.08, rewarding those who trusted the recommendation.

AYTU

Buy

Jul 01, 2025

Target

$8.00

Current

$2.18

Performance

-3.54%

On Jul 01, 2025, Thomas Flaten published a Buy outlook on AYTU, with a target of 8. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 2.18.

OCX

Buy

May 21, 2025

Target

$8.00

Current

$3.20

Performance

4.23%

Thomas Flaten on May 21, 2025 assigned OCX a Buy rating, with a price target of 8. The recommendation remains pending validation as shares consolidate around 3.2.

OPTN

Hold

Mar 20, 2025

Target

$9.00

Current

$9.60

Performance

4.92%

On Mar 20, 2025, Thomas Flaten reaffirmed OPTN with a Hold rating, targeting 9. The neutral call matched muted market action of 4.92%.

CKPT

Hold

Mar 10, 2025

Target

$4.10

Current

$4.26

Performance

7.04%

CKPT was rated Hold by Thomas Flaten on Mar 10, 2025, with a price objective of 4.1. Despite caution, upside momentum rewarded risk-takers with gains to 4.26.

AQST

Buy

Mar 07, 2025

Target

$8.00

Current

$4.04

Performance

52.45%

On Mar 07, 2025, Thomas Flaten initiated coverage on AQST with a Buy rating and target of 8. The stock’s climb of 52.45% since the call highlights the foresight in the rating.

Frequency Asked Questions

Who is Thomas Flaten?

Thomas Flaten is an analyst from Lake Street specializing in the Healthcare sector.

What is Thomas Flaten's success rate?

Thomas Flaten currently has a success rate of +66.06%.

How many ratings has Thomas Flaten issued?

Thomas Flaten has issued 16 stock ratings so far.

What is the average return of Thomas Flaten's calls?

Their stock ratings have generated an average return of +20.45%.

What is Thomas Flaten's ranking?

Thomas Flaten is ranked #2312 out of 4738 analysts.

What types of ratings does Thomas Flaten give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Thomas Flaten?

You can follow Thomas Flaten by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Thomas Flaten?

Their latest rating was a Hold on PSNL issued on 2026-07-20.